Udo Rudloff, M.D., Ph.D.
Gastrointestinal Oncology and Hepatobiliary Section
National Cancer Institute
10 Center Drive
Building 10 - Magnuson Clinical Center, Room 4-5950
Bethesda, MD 20892
Dr. Rudloff is an investigator and surgical oncologist at the Surgery Branch, National Cancer Institute, National Institutes of Health, in Bethesda, Maryland. Dr. Rudloff completed his M.D. at the University of Heidelberg, Germany. For his doctoral thesis at the German Cancer Research Institute, Heidelberg, he worked on gene regulation of rRNA transcription. He graduated from New York University in 2007 upon completion of his surgical residency training and pursued subspecialty training in surgical oncology by completing a 2-year surgical oncology fellowship at Memorial Sloan Kettering Center in New York City. He was appointed to the senior staff of the Surgery Branch/NCI in July 2009.
Dr. Rudloff’s clinical interests lie in the management of complex cancers of the liver, biliary tree, and pancreas. His laboratory efforts focus on preclinical drug development for pancreatic cancer and other GI malignancies in vitro and in vivo models and the design of personalized treatment strategies for the individual genotype of patients’ tumors.
Dr. Rudloff's Clinical Trial(s):
NCI’s Center for Cancer Research (CCR) is currently conducting the following targeted therapy trial for patients with digestive/gastrointestinal cancers. Click on the trial(s) below for additional details, including a summary of primary eligibility, study outline, and information on how to contact the study team directly.